Listed

Emergent BioSolutions Inc.: Form 10-Q for the period ended Mar 31, 2015

Filed with the SEC on May 8, 2015 and accepted by EDGAR at May 7, 2015, 18:43 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2015-03-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2015-01-01 to 2015-03-31$63.6mus-gaap:Revenues
Cost of revenue3 months2015-01-01 to 2015-03-31$18.7mus-gaap:CostOfGoodsSold
Research and development3 months2015-01-01 to 2015-03-31$38.7mus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative3 months2015-01-01 to 2015-03-31$34.5mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2015-01-01 to 2015-03-31−$28.3mus-gaap:OperatingIncomeLoss
Interest expense3 months2015-01-01 to 2015-03-31$1.7mus-gaap:InterestExpense
Income tax3 months2015-01-01 to 2015-03-31−$8.3mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2015-01-01 to 2015-03-31−$21.5mus-gaap:NetIncomeLoss
Diluted EPS3 months2015-01-01 to 2015-03-31−$0.57us-gaap:EarningsPerShareDiluted
Basic EPS3 months2015-01-01 to 2015-03-31−$0.57us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2015-01-01 to 2015-03-3137,949,358 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow3 months2015-01-01 to 2015-03-31−$65.9mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure3 months2015-01-01 to 2015-03-31$9.1mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2015-03-31$216.5mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2015-03-31$405.8mus-gaap:AssetsCurrent
Total assetsAt period end2015-03-31$917.8mus-gaap:Assets
Current liabilitiesAt period end2015-03-31$80.3mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2015-03-31$380.0mus-gaap:Liabilities
Long-term debtAt period end2015-03-31$251.0mus-gaap:LongTermDebtNoncurrent
Shareholders' equityAt period end2015-03-31$537.9mus-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

Source: SEC EDGAR, the filing index for accession 0001367644-15-000027. Last ingested by Listed: Nov 4, 2026, 16:51 ET. Listed shows no prices and gives no investment advice.